Тёмный

Assertio Holdings (ASRT) 1Q 2024 Summary 07May2024 

RunningRobert
Подписаться 878
Просмотров 73
50% 1

Assertio Holdings (ASRT) 1Q 2024 Summary 07May2024
Thank you for watching this video If you like it please like the video and subscribe to my page. Please excuse the spelling I just noticed it
If I have gotten anything wrong please write in the comments, and include any links. If it is a small spelling error or pronunciation error, I will not change the video but will work on it in the next video!
If you liked this video please take a moment to subscribe to my channel.
There are more videos posted in the comments
#stocks #microcapstocks #pharmastocks #asrt #investing
I have other videos which can be viewed below (in date order)
Ardelyx (ARDX) 1Q 2024 Summary 03May2024
• Ardelyx (ARDX) 1Q 2024...
Humacyte (HUMA) Summary 29Apr2024
• Humacyte (HUMA) Summar...
Geron Corp (GERN) Summary 22Apr2024
• Geron Corp (GERN) Summ...
Palatin Technologies Inc PTN P3 Results Summary Did they pass or fail?15Apr2024
• Palatin Technologies I...
Cara Therapeutics CARA Summary 08Apr2024
• Cara Therapeutics CARA...
SCYNEXIS (SCYX) Full Year 2023 Summary 01Apr2024
• SCYNEXIS (SCYX) Full Y...
Bluebird Bio BLUE Q4 and 2023 Summary 27Mar2024
• Bluebird Bio BLUE Q4 a...
Lipocine Inc LPCN 2023 Summary 25Mar2024
• Lipocine Inc LPCN 2023...
Assertio Holdings ASRT 4Q and Yearly 2023 Summary 20Mar2023
• Assertio Holdings ASRT...
Protalix BioTherapeutics PLX 4Q and Yearly Summary 18Mar2024
• Protalix BioTherapeuti...
Geron Corp GERN Post ADCOM Summary 15Mar2024
• Geron Corp GERN Post A...
Aquestive Therapeutics (AQST) Q4 2023 and Yearly Summary 11Mar2024
• Aquestive Therapeutics...
Xeris Pharmaceuticals (XERS) Q4 2023 and Full year Summary 07Mar2024
• Xeris Pharmaceuticals ...
Geron Corp (GERN) 4Q Quarterly and Pre ADCOM Summary 04Mar2024
• Geron Corp (GERN) 4Q Q...
Palatin Technologies Inc (PTN) P3 Results Summary 29Feb2024
• Palatin Technologies I...
Ardelyx (ARDX) 4Q 2023 Summary 23Feb2024
• Ardelyx (ARDX) 4Q 2023...
Elite Pharmaceuticals ELTP Q3 2024 Earnings Summary 20Feb2024
• Elite Pharmaceuticals ...
Palatin Technologies Inc PTN Q2 2024 Summary 16Feb2024
• Palatin Technologies I...
Merrimack Pharmaceuticals MACK Approval Summary 14Feb2024
• Merrimack Pharmaceutic...
Anavex Life Sciences Corp AVXL 1Q 2024 Summary 08Feb2024
• Anavex Life Sciences C...
Palatin Technologies Inc (PTN) Offering Summary 31Jan2024
• Palatin Technologies I...
Cara Therapeutics (CARA) Summary 29Jan2024
• Cara Therapeutics (CAR...
Akebia Therapeutics (AKBA) Summary 22Jan2024
• Akebia Therapeutics (A...
Lipocine Inc LPCN Tlando and LPCN 1154 Summary 19Jan2024
• Lipocine Inc LPCN Tlan...
Palatin Technologies Inc (PTN) MELODY-1 Data Delay Summary 16Jan2024
• Palatin Technologies I...
Xeris Pharmaceuticals (XERS) Licensing deal with Amgen Summary 11Jan2024
• Xeris Pharmaceuticals ...
Ardelyx (ARDX) Update Guidance Summary 10Jan2024
• Ardelyx (ARDX) Update ...
Xeris Pharmaceuticals XERS Guidance Summary 08Jan2024
• Xeris Pharmaceuticals ...
Anavex Life Sciences Corp AVXL Clinical Update Summary 03Jan2024
• Anavex Life Sciences C...
Geron Corp GERN Summary 02Jan2024
• Geron Corp GERN Summar...
Palatin Technologies Inc (PTN) Vyleesi Deal Summary 22Dec2023
• Palatin Technologies I...
Bluebird Bio (BLUE) Wow that’s a lot of dilution Summary 21Dec2023
• Bluebird Bio (BLUE) Wo...

Опубликовано:

 

26 сен 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 2   
@omarc4ut
@omarc4ut 4 месяца назад
I gought in 80 cents. Long term, what do you think the ceiling is for this company? I am asking because I am trying to figure out if I should sell at $2 or keep it for highter returns in two or three years. Thanks for the great information.
@runningrobert
@runningrobert 4 месяца назад
The best price wont be determined until ROLVEDON value is truly discovered. So if they end up selling around 100M a year, based on the expenses, I would expect 3-4 to be the high, if they can push it to 400M a year, then 15-20 could be the high. I am very curious how the 2Q will go, because that will give us a good indication of growth, since looking at 1Q are rough since there are insurance changes and such that can affects sales. I do expect a decent ramp up of sales so that why I said we would see 2 this year!
Далее
Kenji's Sushi Shop Showdown - Brawl Stars Animation
01:55
The Road Ahead for E.V.s with RJ Scaringe
27:20
Просмотров 12 тыс.
Coinbase Q1 2024 Earnings Call
43:52
Просмотров 7 тыс.
How does the stock market work? - Oliver Elfenbaum
4:30
Rate cuts could fuel an 'upswing' for these sectors
5:34